MENU

CHRS Coherus BioSciences Forecast, Technical & Fundamental Analysis

a maker of biologic therapeutics for oncology and inflammatory diseases

Industry Biotechnology
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CHRS is expected to report earnings to rise 2,947.00% to -30 cents per share on February 27

Coherus BioSciences CHRS Stock Earnings Reports
Q4'24
Est.
$-0.30
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.11
Q1'24
Missed
by $0.07
Q4'23
Missed
by $0.41
The last earnings report on November 06 showed earnings per share of 0 cents, beating the estimate of -15 cents. With 3.16M shares outstanding, the current market capitalization sits at 179.73M.
A.I. Advisor
published General Information

General Information

a maker of biologic therapeutics for oncology and inflammatory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Twin Dolphin Drive
Phone
+1 650 649-3530
Employees
306
Web
https://www.coherus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CHRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with XENE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHRS
1D Price
Change %
CHRS100%
+0.59%
XENE - CHRS
40%
Loosely correlated
-0.07%
QSI - CHRS
37%
Loosely correlated
-8.67%
BPMC - CHRS
36%
Loosely correlated
+1.14%
RCUS - CHRS
35%
Loosely correlated
-2.60%
PRME - CHRS
34%
Loosely correlated
-3.00%
More